| 臺大學術典藏 |
2022-04-14T23:27:22Z |
Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination
|
WANG-HUEI SHENG; SUI-YUAN CHANG; Lin, Pin Hung; MING-JU HSIEH; Chang, Hao Hsiang; Cheng, Chien Yu; HUNG-CHIH YANG; Pan, Ching Fu; Ieong, Si Man; Chao, Tai Ling; Chen, Jang Pin; Cheng, Shu Hsing; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2022-03-14T23:44:58Z |
Transporter Genes and fosA Associated With Fosfomycin Resistance in Carbapenem-Resistant Klebsiella pneumoniae
|
Wang, Yu Ping; Chen, Yen Hao; Hung, I. Cheng; Chu, Po Hsun; Chang, Yu Han; Lin, Yi Tsung; HUNG-CHIH YANG; JIN-TOWN WANG |
| 臺大學術典藏 |
2022-02-14T23:55:08Z |
Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma
|
Wang, Sung Yin; TUNG-HUNG SU; BANG-BIN CHEN; CHUN-JEN LIU; CHEN-HUA LIU; HUNG-CHIH YANG; Tseng, Tai Chung; PEI-JER CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-15T00:07:35Z |
Recent progress and future prospective in HBV cure by CRISPR/cas
|
Yang, Yu Chan; HUNG-CHIH YANG |
| 臺大學術典藏 |
2021-12-14T23:11:55Z |
Isolation or De-isolation? Measuring the Infectivity of Severe Acute Respiratory Syndrome Coronavirus 2
|
HUNG-CHIH YANG |
| 臺大學術典藏 |
2021-12-14T23:11:55Z |
Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan
|
CHUN-MING HONG; Lin, You Yu; CHUN-JEN LIU; Lai, Ya Yun; Shiou-Hwei Yeh; HUNG-CHIH YANG; JIA-HORNG KAO; Hsu, Shih Jer; Huang, Yi Hsiang; Yang, Sheng Shun; Kuo, Hsing Tao; Cheng, Pin Nan; Yu, Ming Lung; PEI-JER CHEN |
| 臺大學術典藏 |
2021-10-21T23:27:05Z |
Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients (Hepatology International, (2021), 15, 3, (582-592), 10.1007/s12072-021-10186-7)
|
Cheng, Huei Ru; HUNG-CHIH YANG; Lin, Su Ru; Yang, Ta Yu; Lin, You Yu; TUNG-HUNG SU; Tseng, Tai Chung; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-10-21T23:27:05Z |
Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents
|
Huang, Shang Chin; Cheng, Pin Nan; CHEN-HUA LIU; HUNG-CHIH YANG; TUNG-HUNG SU; Tseng, Tai Chung; PEI-JER CHEN; JIA-HORNG KAO; CHUN-JEN LIU |
| 臺大學術典藏 |
2021-09-14T23:18:28Z |
Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis
|
TUNG-HUNG SU; Peng, Cheng Yuan; Chang, Shan Han; Tseng, Tai Chung; CHUN-JEN LIU; CHI-LING CHEN; CHEN-HUA LIU; HUNG-CHIH YANG; PEI-JER CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-08-15T00:07:45Z |
Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients
|
Cheng, Huei Ru; HUNG-CHIH YANG; Lin, Su Ru; Yang, Ta Yu; Lin, You Yu; TUNG-HUNG SU; Tseng, Tai Chung; CHUN-JEN LIU; Kao, Jia-Horng |
| 臺大學術典藏 |
2021-08-15T00:07:45Z |
Dynamics of cellular immune responses in recipients of renal allografts positive for hepatitis B surface antigen
|
YA-WEN YANG; CHIEN-CHIA CHEN; Yang, Ching Yao; Lee, Chih Yuan; HUNG-CHIH YANG; BOR-LUEN CHIANG; YA-HUI CHUANG; Wu, Tiffany E.; HONG-SHIEE LAI; MENG-KUN TSAI |
| 臺大學術典藏 |
2021-07-12T03:12:56Z |
Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients
|
Cheng, Huei-Ru; HUNG-CHIH YANG; Lin, Su-Ru; Yang, Ta-Yu; Lin, You-Yu; Su, Tung-Hung; Tseng, Tai-Chung; Liu, Chun-Jen; Kao, Jia-Horng |
| 臺大學術典藏 |
2021-07-12T02:50:43Z |
Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients
|
Cheng, Huei-Ru; HUNG-CHIH YANG; Lin, Su-Ru; Yang, Ta-Yu; Lin, You-Yu; Su, Tung-Hung; Tseng, Tai-Chung; Liu, Chun-Jen; Kao, Jia-Horng |
| 臺大學術典藏 |
2021-07-12T02:44:52Z |
Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation
|
HUNG-CHIH YANG; | Shen L; | Siliciano R.F; | Pomerantz J.L. |
| 臺大學術典藏 |
2021-07-12T02:44:52Z |
Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation
|
HUNG-CHIH YANG; | Xing S; | Shan L; | O'Connell K; | Dinoso J; | Shen A; | Zhou Y; | Shrum C.K; | Han Y; | Liu J.O; | Zhang H; | Margolick J.B; | Siliciano R.F. |
| 臺大學術典藏 |
2021-07-12T02:44:51Z |
Primary cell models of HIV latency
|
HUNG-CHIH YANG |
| 臺大學術典藏 |
2021-07-12T02:44:49Z |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
|
HUNG-CHIH YANG; | Chen C.-L; | Shen Y.-C; | Peng C.-Y; | Liu C.-J; | Tseng T.-C; | Su T.-H; | Chuang W.-L; | Yu M.-L; | Dai C.-Y; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:45Z |
Hepatitis B virus: Pathogenesis and host immune response
|
HUNG-CHIH YANG; | Yeh S.-H; | Chen P.-J; | Chen D.-S. |
| 臺大學術典藏 |
2021-07-12T02:44:44Z |
Viral hepatitis: HBV cure-can we pin our hopes on immunotherapy?
|
HUNG-CHIH YANG; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:44Z |
Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: Molecular mechanisms and clinical significance
|
HUNG-CHIH YANG; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:39Z |
Looking into the crystal ball: biomarkers for outcomes of HBV infection
|
HUNG-CHIH YANG; | Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:37Z |
Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B
|
HUNG-CHIH YANG; | Shih Y.-F; | Liu C.-J. |
| 臺大學術典藏 |
2021-07-12T02:44:34Z |
The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA
|
HUNG-CHIH YANG; | Chen P.-J. |
| 臺大學術典藏 |
2021-07-12T02:44:34Z |
Viral factors affecting disease progression
|
HUNG-CHIH YANG |
| 臺大學術典藏 |
2021-07-12T02:44:31Z |
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
|
HUNG-CHIH YANG; | Tsou H.-H; | Pei S.-N; | Chang C.-S; | Chen J.-H; | Yao M; | Lin S.-J; | Lin J; | Yuan Q; | Xia N; | Liu T.-W; | Chen P.-J; | Cheng A.-L; | Hsu C; | Taiwan Cooperative Oncology Group |
